Resonance Health (ASX:RHT) Debt-to-Equity : 0.03 (As of Dec. 2023)

View and export this data going back to 1987. Start your Free Trial

What is Resonance Health Debt-to-Equity?

Resonance Health's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$0.13 Mil. Resonance Health's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$0.19 Mil. Resonance Health's Total Stockholders Equity for the quarter that ended in Dec. 2023 was A$9.84 Mil. Resonance Health's debt to equity for the quarter that ended in Dec. 2023 was 0.03.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Resonance Health's Debt-to-Equity or its related term are showing as below:

ASX:RHT' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01 Med: 0.03 Max: 0.03
Current: 0.03

During the past 13 years, the highest Debt-to-Equity Ratio of Resonance Health was 0.03. The lowest was 0.01. And the median was 0.03.

ASX:RHT's Debt-to-Equity is ranked better than
90.76% of 552 companies
in the Healthcare Providers & Services industry
Industry Median: 0.49 vs ASX:RHT: 0.03

Resonance Health Debt-to-Equity Historical Data

The historical data trend for Resonance Health's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Resonance Health Debt-to-Equity Chart

Resonance Health Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Debt-to-Equity

Get a 7-Day Free Trial

0.01

0.03

Resonance Health Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															0.03	0.03	0.03	0.03	0.03

Competitive Comparison of Resonance Health's Debt-to-Equity

For the Health Information Services subindustry, Resonance Health's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Resonance Health's Debt-to-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Resonance Health's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Resonance Health's Debt-to-Equity falls into.

Resonance Health Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Resonance Health's Debt to Equity Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.1	+	0.173)	/	9.935
	=	0.03

Resonance Health's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.127	+	0.194)	/	9.838
	=	0.03

Resonance Health (ASX:RHT) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Resonance Health Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Resonance Health's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Resonance Health (ASX:RHT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Resonance Health Ltd (ASX:RHT) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

141 Burswood Road, Level 1, Burswood, WA, AUS, 6100

Website

https://www.resonancehealth.com

Resonance Health Ltd is a healthcare company specializing in the development and commercialization of technologies and services for the quantitative analysis of radiological images in a regulated and quality-controlled environment. Its product includes FerriScan, a non-invasive liver diagnostic technology used for the measurement of iron in the liver, and HepaFat-Scan. The company's operating segment includes Services; Research and Development and Corporate. It generates maximum revenue from the Services segment. Geographically, it derives a majority of its revenue from North America and Europe-Middle-East-Africa (EMEA) and also has a presence in Asia/Pacific.

Resonance Health (ASX:RHT) Headlines

No Headlines